Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-08 Purchase |
2021-12-10 4:05 pm |
Nautilus Biotechnology Inc. | NAUT | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
200,000 | $5.36 | $1,072,000 | 9,111,151 (Indirect) |
View |
| 2021-11-30 Purchase |
2021-12-02 08:49 am |
Nautilus Biotechnology Inc. | NAUT | Patel Sujal M CEO, President, and Secretary 10% Owner |
250,000 | $4.7247 | $1,181,176 | 16,958,899 (Indirect Direct) |
View |
| 2021-11-30 Purchase |
2021-12-01 9:41 pm |
Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director |
50,000 | $4.5101 | $225,505 | 150,000 (Indirect Direct) |
View |
| 2021-11-24 Purchase |
2021-11-24 5:12 pm |
Nautilus Biotechnology Inc. | NAUT | Mowry Anna CFO and Treasurer |
15,000 | $4.5755 | $68,633 | 32,500 (Direct) |
View |
| 2021-11-15 Purchase |
2021-11-17 8:19 pm |
Nautilus Biotechnology Inc. | NAUT | McIlwain Matthew S Director |
100,000 | $5.2989 | $529,890 | 6,479,845 (Indirect Direct) |
View |
| 2021-08-24 Purchase |
2021-08-26 7:29 pm |
Nautilus Biotechnology Inc. | NAUT | McIlwain Matthew S Director |
36,970 | $7.7101 | $285,041 | 6,379,845 (Indirect Direct) |
View |
| 2021-08-12 Purchase |
2021-08-16 5:12 pm |
Nautilus Biotechnology Inc. | NAUT | Mowry Anna CFO and Treasurer |
17,500 | $7.71 | $134,925 | 17,500 (Direct) |
View |
| 2021-08-13 Purchase |
2021-08-13 9:01 pm |
Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel |
5,000 | $7.5613 | $37,807 | 34,140 (Indirect) |
View |
| 2021-05-24 Purchase |
2021-06-11 5:45 pm |
Nautilus Biotechnology Inc. | NAUT | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Former Director Director |
5,507,063 | $10 | $55,070,983 | 12,322,302 (Indirect Direct) |
View |
| 2021-06-03 Purchase |
2021-06-03 6:55 pm |
ARYA Sciences Acquisition Corp III | ARYA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
330,050 | $10.05 | $3,317,003 | 489,975 (Indirect) |
View |
| 2021-05-20 Purchase |
2021-05-24 6:49 pm |
ARYA Sciences Acquisition Corp III | ARYA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
159,925 | $10.05 | $1,607,246 | 159,925 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-14 Option Award |
2021-08-04 8:01 pm |
N/A 2031-06-14 |
Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel |
326,526 | $0 | 326,526 (Direct) |
View |
| 2021-06-09 Other |
2021-06-11 5:45 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Former Director Director |
2,914,113 | $0 | 12,322,302 (Indirect) |
View |
| 2021-06-09 Option Award |
2021-06-11 5:32 pm |
2021-06-09 2031-06-09 |
Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director |
44,435 | $0 | 543,435 (Direct) |
View |
| 2021-06-09 Conversion |
2021-06-11 5:32 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director |
4,146,500 | $0 | 543,435 (Indirect) |
View |
Ownership |
2021-06-09 9:42 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel |
0 | $0 | 29,140 (Indirect) |
View |
Ownership |
2021-06-09 9:41 pm |
N/A 2031-01-31 |
Nautilus Biotechnology Inc. | NAUT | Epperly Melissa B Director |
0 | $0 | 72,561 (Direct) |
View |
Ownership |
2021-06-09 9:41 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | Mallick Parag Chief Scientist 10% Owner |
0 | $0 | 21,153,911 (Direct) |
View |
Ownership |
2021-06-09 9:41 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | McIlwain Matthew S Director |
0 | $0 | 6,379,155 (Direct) |
View |
Ownership |
2021-06-09 9:40 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | AH Equity Partners Bio II L.L.C. Andreessen Horowitz LSV Fund II L.P. AH Bio Fund II L.P. Andreessen Horowitz LSV Fund II-B L.P. AH Bio Fund II-B L.P. AH Equity Partners LSV II L.L.C. Andreessen Horowitz LSV Fund II-Q L.P. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner |
0 | $0 | 17,653,917 (Indirect) |
View |
Ownership |
2021-06-09 9:40 pm |
N/A 2030-12-03 |
Nautilus Biotechnology Inc. | NAUT | Mowry Anna CFO and Treasurer |
0 | $0 | 435,368 (Direct) |
View |
Ownership |
2021-06-09 9:39 pm |
N/A 2030-10-15 |
Nautilus Biotechnology Inc. | NAUT | Nelson Nicholas A. CBO & Senior VP, Bus. Dev. |
0 | $0 | 816,315 (Direct) |
View |
Ownership |
2021-06-09 9:39 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | Pande Vijay Satyanand Director |
0 | $0 | 17,690,197 (Indirect) |
View |
Ownership |
2021-06-09 9:39 pm |
N/A 2030-12-03 |
Nautilus Biotechnology Inc. | NAUT | Sankar Subramanian Senior VP, Product Development |
0 | $0 | 725,614 (Direct) |
View |
Ownership |
2021-06-09 9:38 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | Patel Sujal M CEO, President, and Secretary 10% Owner |
0 | $0 | 17,497,732 (Direct) |
View |
Ownership |
2021-06-09 9:38 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | NAZEM FARZAD Director |
0 | $0 | 1,924,426 (Indirect) |
View |
Ownership |
2021-06-09 9:38 pm |
N/A N/A |
Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director |
0 | $0 | 368,476 (Indirect) |
View |
| 2020-08-11 Other |
2020-08-11 8:48 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | ARYA Sciences Holdings III 10% Owner |
499,000 | $10 | 998,000 (Direct) |
View |
| 2020-08-11 Other |
2020-08-11 8:43 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | Stone Adam Leo Chief Executive Officer 10% Owner |
499,000 | $10 | 998,000 (Indirect) |
View |
| 2020-08-11 Other |
2020-08-11 8:38 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner |
499,000 | $10 | 998,000 (Indirect) |
View |
Ownership |
2020-08-06 9:47 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner |
0 | $0 | 3,647,500 (Indirect) |
View |
Ownership |
2020-08-06 9:43 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | ARYA Sciences Holdings III 10% Owner |
0 | $0 | 3,647,500 (Direct) |
View |
Ownership |
2020-08-06 9:41 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | Wider Todd Director |
0 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-08-06 9:40 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | Stone Adam Leo Chief Executive Officer 10% Owner |
0 | $0 | 3,647,500 (Indirect) |
View |
Ownership |
2020-08-06 9:37 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | Islam Saqib Director |
0 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-08-06 9:37 pm |
N/A N/A |
ARYA Sciences Acquisition Corp III | ARYA | Campbell Bradley L Director |
0 | $0 | 30,000 (Direct) |
View |